These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years. Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, Böhm M, Schmieder RE. Nephrol Dial Transplant; 2022 Jan 25; 37(2):304-310. PubMed ID: 34109413 [Abstract] [Full Text] [Related]
44. Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial. Kario K, Yokoi Y, Okamura K, Fujihara M, Ogoyama Y, Yamamoto E, Urata H, Cho JM, Kim CJ, Choi SH, Shinohara K, Mukai Y, Ikemoto T, Nakamura M, Seki S, Matoba S, Shibata Y, Sugawara S, Yumoto K, Tamura K, Yoshihara F, Nakamura S, Kang WC, Shibasaki T, Dote K, Yokoi H, Matsuo A, Fujita H, Takahashi T, Kang HJ, Sakata Y, Horie K, Inoue N, Sasaki KI, Ueno T, Tomita H, Morino Y, Nojima Y, Kim CJ, Matsumoto T, Kai H, Nanto S. Hypertens Res; 2022 Feb 25; 45(2):221-231. PubMed ID: 34654905 [Abstract] [Full Text] [Related]
49. Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial. Jiang X, Mahfoud F, Li W, Dong H, Yu J, Yu S, Chen X, Wang P, Li Z, Lauder L, Wang Z, Ji Z, Dong Y, Han B, Zhu Z, Chen Y, Xu J, Zhao X, Fan W, Xie W, Hubbard B, Hu X, Kario K, Gao R. Circulation; 2024 Nov 12; 150(20):1588-1598. PubMed ID: 39229700 [Abstract] [Full Text] [Related]
50. Association between renal sympathetic denervation and arterial stiffness: the ASORAS study. Zeijen VJM, Feyz L, Kardys I, Geleijnse ML, Van Mieghem NM, Zijlstra F, Lafeber M, Van Der Geest RJ, Hirsch A, Daemen J. J Hypertens; 2023 Mar 01; 41(3):476-485. PubMed ID: 36655697 [Abstract] [Full Text] [Related]
51. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Konstantinidis D, Choi JW, East C, Lee DP, Ma A, Ewen S, Cohen DL, Wilensky R, Devireddy CM, Lea J, Schmid A, Weil J, Agdirlioglu T, Reedus D, Jefferson BK, Reyes D, D'Souza R, Sharp ASP, Sharif F, Fahy M, DeBruin V, Cohen SA, Brar S, Townsend RR, SPYRAL HTN-OFF MED Pivotal Investigators. Lancet; 2020 May 02; 395(10234):1444-1451. PubMed ID: 32234534 [Abstract] [Full Text] [Related]
52. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium. Blood Press; 2015 May 02; 24(5):263-74. PubMed ID: 26194721 [Abstract] [Full Text] [Related]
53. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Wang TD, Lee YH, Chang SS, Tung YC, Yeh CF, Lin YH, Pan CT, Hsu CY, Huang CY, Wu CK, Sung PH, Chiang LT, Wang YC, Tsai WC, Lin TT, Lin CP, Chen WJ, Hwang JJ. Acta Cardiol Sin; 2019 May 02; 35(3):199-230. PubMed ID: 31249454 [Abstract] [Full Text] [Related]
55. Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV. Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B, Dasgupta I, Nickenig G, Ormiston J, Saxena M, Sharp ASP, Sievert H, Spinar J, Starek Z, Weil J, Wenzel U, Witkowski A, Lobo MD. J Hypertens; 2018 Mar 02; 36(3):680-689. PubMed ID: 29035942 [Abstract] [Full Text] [Related]
56. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program. Ojrzanowski M, Kasprzak JD, Peruga JZ, Kurpesa M, Jankowski Ł, Sahni S, Plewka M. Adv Clin Exp Med; 2019 Nov 02; 28(11):1525-1530. PubMed ID: 31693316 [Abstract] [Full Text] [Related]
57. The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial). Peters CD, Mathiassen ON, Vase H, Bech Nørgaard J, Christensen KL, Schroeder AP, Rickers HJVH, Opstrup UK, Poulsen PL, Langfeldt S, Andersen G, Hansen KW, Bøtker HE, Engholm M, Bertelsen JB, Pedersen EB, Kaltoft A, Buus NH. Blood Press; 2017 Dec 02; 26(6):366-380. PubMed ID: 28830251 [Abstract] [Full Text] [Related]
58. Renal denervation in moderate treatment-resistant hypertension. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE. J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901 [Abstract] [Full Text] [Related]
59. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program. Azizi M, Sharp ASP, Fisher NDL, Weber MA, Lobo MD, Daemen J, Lurz P, Mahfoud F, Schmieder RE, Basile J, Bloch MJ, Saxena M, Wang Y, Sanghvi K, Jenkins JS, Devireddy C, Rader F, Gosse P, Claude L, Augustin DA, McClure CK, Kirtane AJ, RADIANCE Investigators. Circulation; 2024 Mar 05; 149(10):747-759. PubMed ID: 37883784 [Abstract] [Full Text] [Related]
60. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study. Gosse P, Cremer A, Kirtane AJ, Lobo MD, Saxena M, Daemen J, Wang Y, Stegbauer J, Weber MA, Abraham J, Kario K, Bangalore S, Claude L, Liu Y, Azizi M. Hypertension; 2021 Feb 05; 77(2):529-536. PubMed ID: 33356403 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]